Fri, Feb 02, 2024
Torrent Pharma Q3 Results: Torrent Pharmaceuticals reported a 52 per cent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023.
More >
Wed, Oct 25, 2023
Operating EBITDA during the period came in at Rs 825 crore, up 22 per cent YoY. In the Q2 period of the previous fiscal, operation profitability was at Rs 679 crore.
Mon, Oct 23, 2023
Torrent Pharma Q2 results: Its net profit in July-September at Rs 386 crore was 23.7 per cent higher than Rs 312 crore net earning in the same period a year back, the company said in a statement. Revenues soared 16 per cent to Rs 2,660 crore.
Thu, Sep 14, 2023
Cipla से जुड़ी Big news related to Cipla: Bids to buy promoters' shares will start soon, bids to buy shares possible by the third week of this month.
Thu, Aug 24, 2023
The Establishment Inspection Report (EIR) was received after the inspection was conducted at the Dahej facility by USFDA between May 17 and May 25, 2023, Torrent Pharma said in a filing to the stock exchanges.
Mon, Aug 21, 2023
Big news for Cipla and TorrentPharma! Can Cipla promoters sell stake? Know full details in this video
Wed, May 31, 2023
Torrent Pharma shares surged to a 52-week high on Wednesday, a day after the drug maker reported a quarterly net profit as against a net loss for the corresponding period a year ago.
Tue, May 30, 2023
Torrent Pharma reported a net profit of Rs 287 crore for the quarter ended March 2023. The board of the Gujarat-based pharma company recommended a dividend of Rs 8 per share, subject to shareholders' approval.
Thu, Mar 23, 2023
Stocks to buy today: In conversation with Zee Business Managing Editor Anil Singhvi, market experts Rakesh Bansal, Sumeet Bagadia, Kunal Saraogi, Himanshu Gupta and Vikas Sethi share their top recommendations for the March 23 session.
Wed, Jan 11, 2023
Jefferies and HSBC have recommended, Cipla, Sun Pharma, Divi's Laboratories, Biocon, Lupin and others
Fri, Sep 30, 2022
global brokerage are bullish on these stocks for investors to take decision and may add these in their portfolio. In this video here you know the full list
Wed, Sep 28, 2022
Torrent Pharma on Tuesday through a regulatory filing said that it will acquire Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment.
Torrent Pharma buys Curatio Health. Acquisition done for ₹2000 crore. GOOD or BAD Deal for Torrent Pharma? What is the opinion of brokerages on the deal? Know full details from Nupur.
Tue, Sep 27, 2022
Torrent Pharmaceuticals on Tuesday said it will acquire Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment.
Mon, Aug 01, 2022
Pharmaceutical companies’ stocks such as Cipla, Zydus Wellness, and Torrent Pharma rose up to 5% on the BSE intraday trade.
Despite healthy Q1FY23 earnings, the pharma major Sun Pharma shares were seen trading flat in the early morning and later declined more than 3 per cent to Rs 913 per share on the BSE intraday on Monday.
Thu, Jul 07, 2022
The brokerage house has advised investors to buy on these stocks. According to the brokerage, this stock can give a return of about 27% from here.
Fri, May 27, 2022
Snapping three day-losing streaks, the Indian market ended higher by nearly one per cent on monthly derivatives expiry day on Thursday.
Wed, May 25, 2022
Q4 Results 2022: Torrent Pharma announced its March quarter results on Wednesday. The company posted Rs 118 crore Q4 loss on impairment provision. Meanwhile, Bata India and Kolte-Patil also declared their January-March quarter result
Thu, Feb 03, 2022
Shares of Torrent Pharmaceutical, Wendt (India) and Cosmo Films would be in action on Thursday as the board of management of these companies have fixed record dates for interim dividend as February 3, 2022
Thu, Jan 27, 2022
Shares of Torrent Pharma were locked in lower circuit as they declined 13 per cent to Rs 2704.80 per share in Thursday's intraday trade on the BSE.
Tue, Apr 13, 2021
In conversation with Zee Business Managing Editor Anil Singhvi, market analyst Siddharth Sedani on Tuesday recommended stocks centred on the 'healing health' theme.
Tue, Feb 09, 2021
Torrent Pharmaceuticals reported healthy performance for Q3 FY21, led by a slightly better than expected operating performance. Revenues for the quarter stood at Rs 1995 cr, up by a meager 1.5% yoy and were in line with the estimates. The operating margins for the quarter stood at 30.4%, up by 296 bps yoy, driven by savings in the other expenses.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.